Prevention of Orbitopathy by Oral or Intravenous Steroid Prophylaxis in Short Duration Graves' Disease Patients Undergoing Radioiodine Ablation: A Prospective Randomized Control Trial Study-Reference-Cited by-同舟云学术

Prevention of Orbitopathy by Oral or Intravenous Steroid Prophylaxis in Short Duration Graves' Disease Patients Undergoing Radioiodine Ablation: A Prospective Randomized Control Trial Study

Published:2019-12-01 Issue:12 Volume:29 Page:1828-1833
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Vannucchi Guia¹,Covelli Danila²,Campi Irene¹,Currò Nicola³,Dazzi Davide⁴,Rodari Marcello⁵,Pepe Giovanna⁵,Chiti Arturo⁵,Guastella Claudio⁶,Lazzaroni Elisa²,Salvi Mario²

Affiliation:

1. Department of Endocrine and Metabolic Diseases, Istituto Auxologico Italiano IRCCS, Milan, Italy.

2. Graves' Orbitopathy Center, Endocrinology, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milan, Italy.

3. Ophthalmology, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milan, Italy.

4. Division of Internal Medicine, Ospedale Vaio, Fidenza, Italy.

5. Department of Nuclear Medicine, Istituto Clinico Humanitas, Milan, Italy.

6. Department of Otolaryngology, University of Milan and Fondazione IRCCS Cà Granda, Milan, Italy.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2019.0150

Reference29 articles.

1. Thyroid-Associated Ophthalmopathy after Treatment for Graves’ Hyperthyroidism with Antithyroid Drugs or Iodine-131

2. Radioiodine therapy (RAI) for Graves’ disease (GD) and the effect on ophthalmopathy: a systematic review*

3. A Prospective Study of the Effects of Radioiodine Therapy for Hyperthyroidism in Patients with Minimally Active Graves’ Ophthalmopathy

4. Use of Corticosteroids to Prevent Progression of Graves' Ophthalmopathy after Radioiodine Therapy for Hyperthyroidism

5. The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thyroid Eye Disease: Epidemiology, Natural History, and Risk Factors;Ophthalmic Plastic & Reconstructive Surgery;2023-12

2. Dysthyroid Optic Neuropathy;Ophthalmic Plastic & Reconstructive Surgery;2023-12

3. Clinical features, pathophysiology, and management of thyroid eye disease;Minerva Ophthalmology;2023-12

4. Aktuelle Therapieansätze der endokrinen Orbitopathie – sind die zielgerichteten Therapien die Zukunft?;Klinische Monatsblätter für Augenheilkunde;2023-10-05

5. Optimization of the treatment of moderate to severe and active thyroid orbitopathy considering the recommendations of the European Group on Graves’ Orbitopathy (EUGOGO) [Optymalizacja leczenia umiarkowanej do ciężkiej i aktywnej orbitopatii tarczycowej z uwzględnieniem zaleceń European Group on Graves’ Orbitopathy (EUGOGO)];Endokrynologia Polska;2022-08-17